Andrew Peller (ADW) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 Apr, 2026Executive summary
Q1 2026 revenue was stable at $99.2 million, with strong performance in western Canada and big box channels offsetting softness in Ontario retail and personal winemaking.
EBITA increased 25.4% to $16.1 million, driven by margin improvements, cost savings, and operational efficiencies.
Net income improved to $4.6 million from a net loss of $0.4 million in Q1 2025.
The company completed the sale of a non-core seven-acre land parcel in BC for $1.3 million, supporting its strategy to focus on high-return assets.
Focus on innovation, premiumization, and expanding presence in both domestic and international markets.
Financial highlights
Q1 FY26 revenue was $99.2 million, nearly flat year-over-year; EBITA rose 25.4% to $16.1 million; gross margin improved by 400bps to 42.4%.
Gross margin rose to $42 million (42.4%), up from 38.4% last year, aided by a $20 million cost-savings program and the Ontario Grape Support Program.
Excluding the Ontario Grape Support Program, gross margin was 40.2%, still showing strong year-over-year growth.
Interest expense decreased by nearly 15% due to lower debt and interest rates.
Cash from operations was $19.2 million, up from $15.3 million in the prior year.
Outlook and guidance
Optimism for the remainder of fiscal 2026, with a strong balance sheet and continued focus on cost savings and operational efficiency.
Management aims for sustained long-term value through above-category sales and EBITA growth.
The company expects to benefit from sustained consumer preference for domestic wines and supportive government policies.
Harvest outlook is positive, with strong expectations in Ontario and improving conditions in the west.
Strategic focus on above-category revenue growth, sustained EBITA growth, and expanded gross margins.
Latest events from Andrew Peller
- Q3 2026 delivered higher revenue, margins, and earnings, with strong growth and a positive outlook.ADW
Q3 202614 Apr 2026 - Q2 margin and earnings growth, cost savings, and retail gains drive a positive outlook.ADW
Q2 20268 Apr 2026 - Q3 revenue and earnings surged on big-box retail growth, margin gains, and cost savings.ADW
Q3 20258 Apr 2026 - Q2 revenue and EBITDA rose on retail gains, but net earnings fell as costs increased.ADW
Q2 20258 Apr 2026 - Record margins and innovation in health-focused products drive growth and future opportunities.ADW
Planet MicroCap Showcase: TORONTO 20253 Feb 2026 - Margin and EBITDA growth, cost savings, and retail gains drive improved results and outlook.ADW
Q4 20243 Feb 2026 - EBITDA/EBITA grew to $12.9M despite a 1% sales drop, driven by cost savings and efficiency.ADW
Q1 20252 Feb 2026 - Net earnings rebounded to $11.1M on record revenue, margin gains, and lower debt.ADW
Q4 202513 Nov 2025 - Double-digit EBITA growth and margin expansion drive renewed profitability and long-term value.ADW
Investor Presentation2 Jul 2025